Early AbobotulinumtoxinA (Dysport®) in Post-Stroke Adult Upper Limb Spasticity: ONTIME Pilot Study

Early AbobotulinumtoxinA (Dysport®) in Post-Stroke Adult Upper Limb Spasticity: ONTIME Pilot Study

The ONTIME study investigated whether early post-stroke abobotulinumtoxinA injection delays appearance or progression of upper limb spasticity (ULS) symptoms. ONTIME (NCT02321436) was a 28-week, exploratory, double-blind, randomized, placebo-controlled study of abobotulinumtoxinA 500U in patients wi...

Full description

Bibliographic Details
Main Authors: Raymond L Rosales, Jovita Balcaitiene, Hugues Berard, Pascal Maisonobe, Khean Jin Goh, Witsanu Kumthornthip, Mazlina Mazlan, Lydia Abdul Latif, Mary Mildred D. Delos Santos, Chayaporn Chotiyarnwong, Phakamas Tanvijit, Odessa Nuez, Keng He Kong
Format: Article
Language:English
Published: MDPI AG 2018-06-01
Series:Toxins
Subjects:
abobotulinumtoxinA
botulinum toxin type A
upper limb spasticity
post-stroke
early use
ONTIME
Online Access:http://www.mdpi.com/2072-6651/10/7/253

Internet

http://www.mdpi.com/2072-6651/10/7/253

Similar Items